NU
Neuren Pharmaceuticals Limited
NURPF · OTC
$16.10 +0.00% (+$0.00)
1M -0.62%
Market Cap $2.85B
P/E Ratio 93.72x
Div. Yield -
ROE 8.96%
Bulios Fair Price
$23.75
47.5% upside
Trenutna cena
$16.1
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NURPF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
17 /100
Expensive P/E 93.72x
EV/EBITDA 129.19x
P/S 44.13x
Growth
100 /100
Growing EPS growth 455.51%
Rev. growth 64.35%
FCF growth 227.14%
Profitability
100 /100
Strong Gross margin 99.96%
Net margin 47.09%
Op. margin 34.07%
Quality
37 /100
Average ROIC 5.09%
ROE 8.96%
ROA 8.88%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 76.60x
Net debt/EBITDA -0.19x
Stability
17 /100
Unstable Beta 1.59x
Rev. volatility 885.08%
EPS volatility 49,454.60%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NURPF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan Charles Pilcher
Employees
8
Headquarters
Hawthorn East
Prihajajoči dogodki
15 SEP.
Ex-Dividend
Ex-dividend date
07 OKT.
Dividend Payment
Datum plačila
24 FEB.
Earnings
Upcoming earnings report